BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37918792)

  • 21. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models.
    Céspedes MV; Guillén MJ; López-Casas PP; Sarno F; Gallardo A; Álamo P; Cuevas C; Hidalgo M; Galmarini CM; Allavena P; Avilés P; Mangues R
    Dis Model Mech; 2016 Dec; 9(12):1461-1471. PubMed ID: 27780828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.
    Yang H; Fan S; An Y; Wang X; Pan Y; Xiaokaiti Y; Duan J; Li X; Tie L; Ye M; Li X
    Oncotarget; 2016 Dec; 7(50):83641-83656. PubMed ID: 27845899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.
    Belli C; Piemonti L; D'Incalci M; Zucchetti M; Porcu L; Cappio S; Doglioni C; Allavena P; Ceraulo D; Maggiora P; Dugnani E; Cangi MG; Garassini G; Reni M
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):477-84. PubMed ID: 26666646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death.
    Passacantilli I; Panzeri V; Terracciano F; Delle Fave G; Sette C; Capurso G
    Oncol Rep; 2018 Apr; 39(4):1984-1990. PubMed ID: 29393478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
    Karelia DN; Kim S; K Pandey M; Plano D; Amin S; Lu J; Sharma AK
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways.
    Wang F; Tian X; Zhang Z; Ma Y; Xie X; Liang J; Yang C; Yang Y
    Int J Cancer; 2018 May; 142(9):1938-1951. PubMed ID: 29238973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.
    Giovannetti E; Mey V; Danesi R; Mosca I; Del Tacca M
    Clin Cancer Res; 2004 May; 10(9):2936-43. PubMed ID: 15131028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis Pathway.
    Rasam S; Lin Q; Shen S; Straubinger RM; Qu J
    J Proteome Res; 2023 Dec; 22(12):3780-3792. PubMed ID: 37906173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer.
    Ono H; Basson MD; Ito H
    Oncotarget; 2016 Aug; 7(32):51301-51310. PubMed ID: 27322077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.
    Maftouh M; Avan A; Sciarrillo R; Granchi C; Leon LG; Rani R; Funel N; Smid K; Honeywell R; Boggi U; Minutolo F; Peters GJ; Giovannetti E
    Br J Cancer; 2014 Jan; 110(1):172-82. PubMed ID: 24178759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma.
    Hii LW; Lim SE; Leong CO; Chin SY; Tan NP; Lai KS; Mai CW
    BMC Complement Altern Med; 2019 Sep; 19(1):257. PubMed ID: 31521140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells.
    Li X; Kong R; Hou W; Cao J; Zhang L; Qian X; Zhao L; Ying W
    Cell Oncol (Dordr); 2024 Feb; 47(1):141-156. PubMed ID: 37639207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
    Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine.
    Li Y; Singh B; Ali N; Sarkar FH
    Int J Mol Med; 1999 Jun; 3(6):647-53. PubMed ID: 10341297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer.
    Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
    Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
    Suzuki K; Aiura K; Matsuda S; Itano O; Takeuchi O; Umezawa K; Kitagawa Y
    Clin Exp Metastasis; 2013 Apr; 30(4):381-92. PubMed ID: 23111540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
    Bao GQ; Shen BY; Pan CP; Zhang YJ; Shi MM; Peng CH
    Toxicol Lett; 2013 Sep; 222(1):23-35. PubMed ID: 23845849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
    Donadelli M; Costanzo C; Beghelli S; Scupoli MT; Dandrea M; Bonora A; Piacentini P; Budillon A; Caraglia M; Scarpa A; Palmieri M
    Biochim Biophys Acta; 2007 Jul; 1773(7):1095-106. PubMed ID: 17555830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
    Park JK; Lee EJ; Esau C; Schmittgen TD
    Pancreas; 2009 Oct; 38(7):e190-9. PubMed ID: 19730150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.